Do Shingrix (recombinant zoster vaccine) and COVID-19 vaccines share any excipients, what are the components of COVID-19 vaccines, and when does protective immunity develop after vaccination?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Shared Ingredients and COVID-19 Vaccine Components

Shingrix and COVID-19 mRNA vaccines share polysorbate 80 as a common excipient, though it appears in different formulations across vaccine platforms. 1, 2

Common Ingredients Between Shingrix and COVID-19 Vaccines

The overlap depends on which COVID-19 vaccine platform you're comparing:

Polysorbate 80 is the key shared ingredient:

  • Shingrix contains: Polysorbate 80 (0.08 mg per dose) 1
  • COVID-19 adenoviral vector vaccines (AstraZeneca, Johnson & Johnson): Contain polysorbate 80 2
  • COVID-19 mRNA vaccines (Pfizer-BioNTech, Moderna): Do NOT contain polysorbate 80; they contain polyethylene glycol (PEG) instead 2

Important caveat: While polysorbate and PEG are chemically distinct, they can cross-react immunologically. Patients with severe allergic reactions to PEG should avoid polysorbate-containing vaccines and vice versa, as both can trigger IgE-mediated mast cell degranulation 2, 3.

What's in COVID-19 Vaccines

mRNA Vaccines (Pfizer-BioNTech, Moderna):

  • Active component: Messenger RNA encoding SARS-CoV-2 spike protein
  • Lipid nanoparticle delivery system: Contains polyethylene glycol (PEG/macrogol)
  • Mechanism: mRNA is taken up by dendritic cells, ribosomes translate it to produce spike protein, triggering neutralizing antibody production 4
  • Key point: These do NOT enter the nucleus, do NOT alter human DNA, and are NOT live virus vaccines 4

Adenoviral Vector Vaccines (AstraZeneca, Johnson & Johnson):

  • Active component: Replication-deficient adenovirus carrying spike protein gene
  • Contains: Polysorbate 80 2
  • Note: These are NOT live-virus vaccines in the traditional sense 5

Timeline to Immunity After COVID-19 Vaccination

Protective immunity develops approximately 2 weeks after completing the vaccine series, though this varies by platform and individual factors:

Standard Timeline:

  • mRNA vaccines (2-dose series):

    • Pfizer: Doses given 21 days apart 4
    • Moderna: Doses given 28 days apart 4
    • Immunity: Robust protection begins ~2 weeks after the second dose

  • Single-dose vaccines (Johnson & Johnson):

    • Immunity: Develops ~2 weeks after the single dose

Special Considerations:

Immunocompromised patients may require additional time or doses:

  • Patients on immunosuppressive medications (rituximab, high-dose corticosteroids, chemotherapy) may have delayed or diminished immune responses 2, 6, 2
  • CDC recommends 2-3 doses for moderately/severely immunocompromised individuals 7
  • Vaccination should ideally occur at least 2 weeks before starting immunosuppressive therapy 7

Medication timing matters:

  • Methotrexate: Withhold 1-2 weeks after each dose to optimize response 6, 2
  • Anti-CD20 agents (rituximab): Schedule vaccination 4 weeks before and delay next dose 2-4 weeks after final vaccine dose 6, 2
  • JAK inhibitors: Withhold 1-2 weeks around vaccination 6, 2

Critical pitfall: Patients who receive monoclonal antibodies or convalescent plasma for COVID-19 treatment should defer vaccination for ≥90 days 5.

References

4
Guideline

covid-19 and novel mrna vaccines in pregnancy: an updated literature review.

BJOG : an international journal of obstetrics and gynaecology, 2022

Related Questions

In a 48-year-old patient who has just had shingles, should the recombinant zoster vaccine (Shingrix) be administered immediately or wait until age 50?
What are the common side effects of COVID‑19 vaccines and when do they typically occur?
What safety concerns and side effects do immunologists associate with mRNA COVID‑19 vaccines (Pfizer‑BNT162b2 and Moderna‑mRNA‑1273), including myocarditis, pericarditis, anaphylaxis, and reduced efficacy in patients with uncontrolled autoimmune disease or on high‑dose immunosuppressants?
What are the typical symptoms of COVID-19 vaccine syndrome and how should they be treated?
Can an allergy to the flu vaccine appear 2 days after vaccination?
What does a CK-MB level of 5.3 indicate and how should it be managed?
In a patient with [LOCATION] syndrome presenting with urinary incontinence, persistent nausea, dental caries, back pain, and syncope, what further work‑up and management steps are indicated after basic labs and cardiology referral?
What is the normal folate (vitamin B9) level in an adult?
What is the recommended dosing schedule for prazosin?
What is the clinical significance of a serum folate level of 1.9 ng/mL and how should it be managed?
Does meclizine cause dizziness, and why is it prescribed for dizziness?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.